1 ClinicalTrials.gov PL 110-85 Implementation Nick Ide Chief Architect, ClinicalTrials.gov National Library of Medicine (Contractor) May 12, 2008.

Slides:



Advertisements
Similar presentations
May Expansion of Clinical Trial Registration and Results Reporting Requirements Deborah A. Zarin, M.D. ClinicalTrials.gov National Library of Medicine.
Advertisements

NCI Clinical Trials Reporting Program CTRP User Meeting November 2, 2011 Gene Kraus CTRP Program Director.
FOCUS ON NLM RESOURCES: CLINICALTRIALS.GOV. WHAT IS A CLINICAL STUDY?  Research study using human subjects.  Volunteers may have a certain disease or.
NCIs Clinical Trials Reporting Program (CTRP) vs. Clinicaltrials.gov
ICTR The Johns Hopkins Institute for Clinical and Translational Research Preparing for ClinicalTrials.gov Results Reporting and Module 2: Baseline Characteristics.
Clinical Trials Registry Susan Koenig, MPP&PA Director, Office of Compliance & Quality University of Missouri-Columbia School of Medicine Compliance &
Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: 27 Sept 2010.
A service of the U.S. National Institutes of Health Module 1: Clinical Trials and Requirements for Registration and Results Reporting.
The Registration of Clinical Trials Deborah A. Zarin, M.D. Director, ClinicalTrials.gov May 2007.
ClinicalTrials.gov Results Reporting from the Ground Up
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
NATIONAL CLINICAL TRIAL (NCT) NUMBER Clinical Trials Management Office December 17, 2014.
1 Session 3 Basic Results Database Deborah A. Zarin, M.D. Background Specific Results Data Elements Data Entry and Display Mockups.
ArtClinica Address: 1175 Marlkress Rd, #2632, Cherry Hill, NJ 08034, USAPhone: Fax: ARTClinica.
New Faculty Orientation August 22, 2012 UAMS Research Support Center Director: Tom Wells (501)
A service of the U.S. National Institutes of Health Module 3: The Librarian’s Role in Advocating to Clinical Researchers.
CTRP User Call November 13, 2013 Gene Kraus CTRP Program Director.
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
1 Session 2 Expanded Clinical Trials Registry Deborah A. Zarin, M.D. NLM Accomplishments Impact to Date Specific Data Element Issues.
CONSORT 2010 Balakrishnan S, Pondicherry Institute of Medical Sciences.
ClinicalTrials.gov: A Primer on Results Reporting 1 Christina McCarthy, MS Senior Compliance and Regulatory Affairs Specialist Boston Children’s Hospital.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Meta-analysis Overview
OnCore Implementation Update
Treatment-Naïve Adults
Emily Ouellette, JD Assistant Director, Partners QI Program
Qualifying Clinical Trials Wendy McAtee – Research Compliance Manager
Background Post-transplant outcomes in adult Fontan patients remain poorly defined. Available studies limited to sub-groups within published registry data.
FDAAA Clinical Trial Disclosure Briefing for GCP/QA SIAC
ClinicalTrials.gov Requirements
Observational Study Working Group
Ryan Cantor, MSPH Director of Statistical Reporting, Intermacs
IST 220 – Intro to Databases
10th Annual Meeting: Friday, March 11th – Products for the Sites
TOPSpro Special Topics
Clinicaltrials.gov Update
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: Sept 2011.
PV-Trend: A JSL Application for Trending Topics for Pharmacovigilance
NIH Clinical Trial Requirements
Statistical Approaches to Support Device Innovation- FDA View
How to Register Your Trial
ClinicalTrials.gov: An introduction
Remote Monitoring of Adverse Events
Supplementary Table 1. PRISMA checklist
IRB Compliance Program PRS Administrator, Brian Brotzman
Randomized Trials: A Brief Overview
EDRN’s Validation Study Information Management System
Clinical Study Results Publication
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: 27 Sept 2010.
CPT and Disclosure: Connecting Critical Processes
Clinical and Translational Science Institute
Remote Monitoring of Adverse Events
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrial.gov Registration & Results Requirements
Claire McKinley, PMP, CCRP
Pilot Studies: What we need to know
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Content downloaded: September 2012.
Common Problems in Writing Statistical Plan of Clinical Trial Protocol
CPT and Disclosure: Connecting Critical Processes
This presentation document has been prepared by Vault Intelligence Limited (“Vault") and is intended for off line demonstration, presentation and educational.
ClinicalTrials.gov Registration & Reporting Requirements
Overall Project RAG Status
IRB Compliance Program PRS Administrator, Brian Brotzman
IEEE GLOBAL HISTORY NETWORK GHN
Masoud Solaymani-Dodaran Iran University of Medical Sciences
ClinicalTrials.gov PRS – How to Register and Maintain a Record
ClinicalTrials.gov PRS – How to Register and Maintain a Record
STEPS Site Report.
Presentation transcript:

1 ClinicalTrials.gov PL Implementation Nick Ide Chief Architect, ClinicalTrials.gov National Library of Medicine (Contractor) May 12, 2008

2 Basic Results By September 27, 2008 –Demographic and baseline characteristics –Number of dropouts –Primary and secondary outcomes –Point of contact –Certain agreements (Restrictions on PI to discuss or publish results)

Data Standards NIH and FDA reviews have not identified data standards directly applicable to summary results ICH E3 is insufficiently structured and unspecific CDISC SDTM is patient level Summary requires thoughtful rollup Intellectual exercise, not blind calculation Ongoing discussions with FDA, CDISC, CTSA groups, and others to coordinate efforts

Overall Approach Web based data entry system Structured data Results tables similar to those in journal articles Use registry data to “pre-populate” key elements of results record –Data can be edited or changed, as necessary (with public tracking of changes) New information can be provided interactively or via XML upload

Challenges and Goals Need to accommodate full range of study designs and data types Need for structure to optimize data quality and search capabilities, and to allow for control over data display Need to be usable by full range of international trial community –Large data providers (e.g., drug companies, NIH ICs) –Academic medical centers –Individual investigators Must accommodate existing practice, even if not considered to be “best practice”

Design Features Tables are “constructed” by the data provider –Columns are pre-set as study arms, but can be changed by the data provider –Rows are measures—some are pre-set, others are customized for each study –Types of measure determines specific design of “cells” Attempt to balance fixed structure with flexibility

7 Basic Results Tables Participant flow –Number started, completed, dropped out by arm Demographic and baseline characteristics –Participant description, overall and per arm Values for primary and secondary outcomes –By arm (“comparison group”) –Scientifically appropriate tests of statistical significance

8 Published Participant Flow Source: Kimmick GG et al. Breast J Mar-Apr;12(2):

9 Participant Flow Number entered study Number completed study Number not completed study Other details –Phase specific information –Study specific information –Number achieved milestones, as specified by registrant

Information Provided By: Unique Protocol ID: Brief Title: NCT ID: Wake Forest University 1234 Sertraline for Hot Flashes NCT

66 women were enrolled and 4 withdrew prior to randomization.

15 Published Baseline Data Source: Kimmick GG et al. Breast J Mar-Apr;12(2):

16 Demographic & Baseline Characteristics Commonly used measures –Age (continuous and categorical) –Gender –Race/Ethnicity –Region of enrollment Measures specific to each trial For each measure –Name of measure –Value, total and by arm –Names and values of categories, if categorical –Measure of dispersion, if continuous

19 Measurement Types Continuous (Years) Multiple Categories

Menopausal Status Baseline # of Subjects Pre Post

22 Published Primary Outcome Source: Kimmick GG et al. Breast J Mar-Apr;12(2):

23 Outcomes Pre-specified primary and secondary outcome measures from registry For each measure –Description –Units –Value by arm or other comparison group Names and values for categories, if categorical Measure of dispersion, if continuous Other details if time to event –Statistics (cont. next slide)

24 Outcomes Statistics (cont.) –Test of non-inferiority? (y/n) If yes, other details –For each p-value provided Name of test (e.g., Chi-squared, ANOVA) Other details/comments –For each confidence interval provided % (e.g., 95% confidence interval) Name of estimate (e.g., OR, RR) Value of estimate Other details/comments

Information Provided By: Unique Protocol ID: Brief Title: NCT ID: Wake Forest University 1234 Sertraline for Hot Flashes NCT

54

0.03

31 DateData EntryData Display May, 2008Requirements analysis complete Post Mock-up Begin development June, 2008Prototype of data entry system Alpha Version August, 2008Beta Version of data entry system Beta Version September 27 th 2008 Public Release Timeline

32 Thank you LISTSERV and other information: